Weblink:
Adjuvant Radiation Therapy or Observation With or Without Early Salvage Radiation Therapy for Men With Node-Positive Prostate Cancer After Surgery and Negative Preoperative Conventional Imaging: A Multicenter Study | Journal of Urology (auajournals.org)
------------------------------
Telix funding Dr Campi in Italy to allow participation in this important study.
------------------------------Journal of UrologyOriginal Research Articles1 Jun 2025Adjuvant Radiation Therapy or Observation With or Without Early Salvage Radiation Therapy for Men With Node-Positive Prostate Cancer After Surgery and Negative Preoperative Conventional Imaging: A Multicenter Study
Purpose:
Our goals were to assess the survival outcomes of adjuvant radiation therapy (aRT) vs observation with or without early salvage radiation therapy for cN0M0 pN1 prostate cancer (PCa) and to create a model for clinical decision-making.
Riccardo Campi
Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
Dr Campi reported receiving a grant from Telix Pharmaceuticals
Telix ASX TLX Breaking News & Current Commentary, page-2773
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$24.49 |
Change
-0.245(0.99%) |
Mkt cap ! $8.278B | |||
| Open | High | Low | Value | Volume |
| $25.24 | $25.27 | $24.44 | $11.62M | 471.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 175 | $24.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $24.49 | 61 | 3 |
View Market Depth
| Last trade - 14.55pm 27/06/2025 (20 minute delay) ? |
| TLX (ASX) Chart |